Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05894889
What this trial is testing

Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC

Who this might be right for
Stage IIIB(N2) Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung Cancer+1 more
Peking University 70
Not applicableStudy completedNCT06617390
What this trial is testing

Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Daiichi Sankyo 1,041
Testing effectiveness (Phase 2)Study completedNCT00690703
What this trial is testing

Radiofrequency Ablation of Pulmonary Tumors Response Evaluation

Who this might be right for
Non Small Cell Lung CancerPulmonary Metastases
Angiodynamics, Inc. 106
Early research (Phase 1)Study completedNCT01295827
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)

Who this might be right for
Cancer, Solid Tumor
Merck Sharp & Dohme LLC 1,260
Not applicableStudy completedNCT00579683
What this trial is testing

Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer

Who this might be right for
Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)
Memorial Sloan Kettering Cancer Center 228
Testing effectiveness (Phase 2)Ended earlyNCT02200354
What this trial is testing

The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab

Who this might be right for
Advanced Non-small Cell Lung Cancer
Kobe City General Hospital 20
Testing effectiveness (Phase 2)UnknownNCT02037997
What this trial is testing

Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Fudan University 80
Testing effectiveness (Phase 2)UnknownNCT02884479
What this trial is testing

An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung Cancer
SciClone Pharmaceuticals International (Cayman) Development Limited 75
Early research (Phase 1)Study completedNCT01840579
What this trial is testing

Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)

Who this might be right for
Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer
Merck Sharp & Dohme LLC 57
Not applicableUnknownNCT04306094
What this trial is testing

Factors Determining the Prognosis in NSCLC Stage IV

Who this might be right for
NSCLC Stage IV
Instituto do Cancer do Estado de São Paulo 217
Not applicableStudy completedNCT00263731
What this trial is testing

Metabolomic Analysis of Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungCarcinoma, Small Cell Lung
University of Louisville 249
Testing effectiveness (Phase 2)Study completedNCT04681131
What this trial is testing

CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
BioAtla, Inc. 85
Testing effectiveness (Phase 2)Ended earlyNCT01222572
What this trial is testing

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerLung CancerNSCLC
Dana-Farber Cancer Institute 1
Testing effectiveness (Phase 2)Study completedNCT01635270
What this trial is testing

Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung CancerRadiation TherapyLocally Advanced Disease+2 more
Centre Leon Berard 54
Testing effectiveness (Phase 2)Looking for participantsNCT07603856
What this trial is testing

A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerMetastatic Lung Cancer
University of Chicago 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT06188702
What this trial is testing

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

Who this might be right for
MTAP-deleted Solid Tumors
Servier Bio-Innovation LLC 60
Testing effectiveness (Phase 2)Looking for participantsNCT03808337
What this trial is testing

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Who this might be right for
Triple Negative Breast CancerNon Small Cell Lung CancerMetastatic Breast Cancer+1 more
Memorial Sloan Kettering Cancer Center 145
Large-scale testing (Phase 3)Study completedNCT02395172
What this trial is testing

Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
EMD Serono Research & Development Institute, Inc. 792
Not applicableActive Not RecruitingNCT04994795
What this trial is testing

Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sophia Genetics SAS 4,000
Large-scale testing (Phase 3)Study completedNCT00002930
What this trial is testing

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Who this might be right for
Esophageal CancerLung Cancer
Memorial Sloan Kettering Cancer Center 75
Next Page